XML 51 R23.htm IDEA: XBRL DOCUMENT v3.23.1
Share-Based Compensation
12 Months Ended
Dec. 31, 2022
Share-Based Compensation  
Share-Based Compensation

14. Share-Based Compensation

The following table presents the Group’s share-based compensation expense by type of award:

    

Year Ended December 31, 

(Amounts in Thousands)

    

2020

    

2021

    

2022

    

2022

RMB

RMB

RMB

US$

Share options

21,837

18,081

24,195

3,508

Non-vested restricted shares

37,952

32,956

18,105

2,625

Total share-based compensation

59,789

51,037

42,300

6,133

During the year ended December 31, 2017, the Group adopted its 2017 share incentive plan (the “2017 Plan”). Under the 2017 Plan, the maximum aggregate number of shares in respect of which options, restricted shares, or restricted share units may be issued shall be 2,800,000 shares. The term of any options, restricted shares, or restricted share units granted under the 2017 Plan shall not exceed ten years. Options, restricted shares or restricted share units generally vest 25% on the first anniversary of the grant date with the remaining 75% vesting ratably over the following 36 months.

During the year ended December 31, 2022, the Group adopted its 2022 share incentive plan (the “2022 Plan”). Under the 2022 Plan, the maximum aggregate number of shares in respect of which options, restricted shares, or restricted share units may be issued shall be 3,000,000 shares. The term of any options, restricted shares, or restricted share units granted under the 2022 Plan shall not exceed ten years. Options, restricted shares or restricted share units generally vest 25% on the first anniversary of the grant date with the remaining 75% vesting ratably over the following 36 months.

Share Options:

No options were granted for the years ended December 31, 2020. The weighted-average grant-date fair value of options granted during the year ended December 31, 2021 and 2022 was RMB306.56 and RMB181.04 (US$26.25) per share. There were 134,639, 37,606 and 6,009 options exercised during the years ended December 31, 2020, 2021 and 2022, respectively.

The Group uses the Black-Scholes pricing model and the following assumptions to estimate the fair value of the options granted:

    

2022

    

Average risk-free rate of return

 

3.0~4.1

%  

Weighted average expected option life

 

7.85

years

Estimated volatility

 

67.1~67.5

%  

Average dividend yield

 

Nil

 

The following table summarizes option activity during the year ended December 31, 2022:

    

    

    

Weighted

    

Weighted

Average

Aggregate

Average

Remaining

Intrinsic

Number of

Exercise

Contractual

Value of

options

Price

Term

Options

    

    

RMB

    

Years

    

RMB

Outstanding as of January 1, 2022

433,968

474.97

7.9

18,389

Granted

558,935

198.71

Exercised

(6,009)

257.59

Forfeited or expired

(61,421)

460.62

Outstanding as of December 31, 2022

925,473

310.49

8.4

8,379

Exercisable as of December 31, 2022

242,581

401.05

6.0

The aggregate intrinsic value of options exercised during the year ended December 31, 2022 was RMB1,223. As of December 31, 2022, there was RMB112,243 of unrecognized compensation expense related to unvested share options, which is expected to be recognized over a weighted average period of 3.93 years.

Non-vested Restricted Shares:

A summary of non-vested restricted share activity during the year ended December 31, 2022 is presented below:

    

    

Weighted-

 

Number of

 

average

 

non-vested

 

grant-

 

restricted

 

date fair

Non-vested restricted shares

shares

 

value

 

RMB

Non-vested as of January 1, 2022

 

150,834

324.12

Granted

 

4,000

224.85

Vested

 

(32,312)

493.62

Forfeited

 

(32,667)

427.29

Non-vested as of December 31, 2022

 

89,855

300.59

The total fair value of non-vested restricted shares vested during the year ended December 31, 2022 was RMB9,672. As of December 31, 2022, there was RMB28,161 in total unrecognized compensation expense related to such non-vested restricted shares, which is expected to be recognized over a weighted-average period of 4.63 years.